Cargando…

The myocardial protective effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery

OBJECTIVE: The aim of the study was to assess the effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery. DESIGN: A randomized prospective study. SETTING: Cairo University, Egypt. MATERIALS AND METHODS: The study included 150 patients undergoing aortic vascular surgery. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Rabie, Zohry, Gomaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070319/
https://www.ncbi.nlm.nih.gov/pubmed/27716690
http://dx.doi.org/10.4103/0971-9784.191570
_version_ 1782461122339667968
author Soliman, Rabie
Zohry, Gomaa
author_facet Soliman, Rabie
Zohry, Gomaa
author_sort Soliman, Rabie
collection PubMed
description OBJECTIVE: The aim of the study was to assess the effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery. DESIGN: A randomized prospective study. SETTING: Cairo University, Egypt. MATERIALS AND METHODS: The study included 150 patients undergoing aortic vascular surgery. INTERVENTION: The patients were classified into two groups (n = 75). Group D: The patients received a loading dose of 1 μg/kg dexmedetomidine over 15 min before induction and maintained as an infusion of 0.3 μg/kg/h to the end of the procedure. Group C: The patients received an equal volume of normal saline. The medication was prepared by the nursing staff and given to anesthetist blindly. MEASUREMENTS: The monitors included the heart rate, mean arterial blood pressure, central venous pressure, electrocardiogram (ECG), serum troponin I level, end-tidal sevoflurane, and total dose of morphine in addition transthoracic echocardiography to the postoperative in cases with elevated serum troponin I level. MAIN RESULTS: The dexmedetomidine decreased heart rate and minimized the changes in blood pressure compared to control group (P < 0.05). Furthermore, it decreased the incidence of myocardial ischemia reflected by troponin I level, ECG changes, and the development of new regional wall motion abnormalities (P < 0.05). Dexmedetomidine decreased the requirement for nitroglycerin and norepinephrine compared to control group (P < 0.05). The incidence of hypotension and bradycardia was significantly higher with dexmedetomidine (P < 0.05). CONCLUSION: The dexmedetomidine is safe and effective in patients undergoing aortic vascular surgery. It decreases the changes in heart rate and blood pressure during the procedures. It provides cardiac protection in high-risk patients reflected by decreasing the incidence of myocardial ischemia and serum level of troponin. The main side effects of dexmedetomidine were hypotension and bradycardia.
format Online
Article
Text
id pubmed-5070319
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-50703192016-11-01 The myocardial protective effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery Soliman, Rabie Zohry, Gomaa Ann Card Anaesth Original Article OBJECTIVE: The aim of the study was to assess the effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery. DESIGN: A randomized prospective study. SETTING: Cairo University, Egypt. MATERIALS AND METHODS: The study included 150 patients undergoing aortic vascular surgery. INTERVENTION: The patients were classified into two groups (n = 75). Group D: The patients received a loading dose of 1 μg/kg dexmedetomidine over 15 min before induction and maintained as an infusion of 0.3 μg/kg/h to the end of the procedure. Group C: The patients received an equal volume of normal saline. The medication was prepared by the nursing staff and given to anesthetist blindly. MEASUREMENTS: The monitors included the heart rate, mean arterial blood pressure, central venous pressure, electrocardiogram (ECG), serum troponin I level, end-tidal sevoflurane, and total dose of morphine in addition transthoracic echocardiography to the postoperative in cases with elevated serum troponin I level. MAIN RESULTS: The dexmedetomidine decreased heart rate and minimized the changes in blood pressure compared to control group (P < 0.05). Furthermore, it decreased the incidence of myocardial ischemia reflected by troponin I level, ECG changes, and the development of new regional wall motion abnormalities (P < 0.05). Dexmedetomidine decreased the requirement for nitroglycerin and norepinephrine compared to control group (P < 0.05). The incidence of hypotension and bradycardia was significantly higher with dexmedetomidine (P < 0.05). CONCLUSION: The dexmedetomidine is safe and effective in patients undergoing aortic vascular surgery. It decreases the changes in heart rate and blood pressure during the procedures. It provides cardiac protection in high-risk patients reflected by decreasing the incidence of myocardial ischemia and serum level of troponin. The main side effects of dexmedetomidine were hypotension and bradycardia. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC5070319/ /pubmed/27716690 http://dx.doi.org/10.4103/0971-9784.191570 Text en Copyright: © 2016 Annals of Cardiac Anaesthesia http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Soliman, Rabie
Zohry, Gomaa
The myocardial protective effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery
title The myocardial protective effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery
title_full The myocardial protective effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery
title_fullStr The myocardial protective effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery
title_full_unstemmed The myocardial protective effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery
title_short The myocardial protective effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery
title_sort myocardial protective effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070319/
https://www.ncbi.nlm.nih.gov/pubmed/27716690
http://dx.doi.org/10.4103/0971-9784.191570
work_keys_str_mv AT solimanrabie themyocardialprotectiveeffectofdexmedetomidineinhighriskpatientsundergoingaorticvascularsurgery
AT zohrygomaa themyocardialprotectiveeffectofdexmedetomidineinhighriskpatientsundergoingaorticvascularsurgery
AT solimanrabie myocardialprotectiveeffectofdexmedetomidineinhighriskpatientsundergoingaorticvascularsurgery
AT zohrygomaa myocardialprotectiveeffectofdexmedetomidineinhighriskpatientsundergoingaorticvascularsurgery